☰

Wendy E. Hartogensis, Ph.D. - Publications

Affiliations: 
2004 University of California, Berkeley, Berkeley, CA, United States 
Area:
Public Health
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Stern J, Solomon A, Dantanarayana A, Pascoe R, Reynaldi A, Davenport MP, Milush J, Deeks SG, Hartogensis W, Hecht FM, Cockerham L, Roche M, Lewin SR. Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 34655216 DOI: 10.1093/infdis/jiab533  0.483
2020 Scharf L, Tauriainen J, Buggert M, Hartogensis W, Nolan DJ, Deeks SG, Salemi M, Hecht FM, Karlsson AC. Delayed Expression of PD-1 and TIGIT on HIV-Specific CD8 T Cells in Untreated HLA-B*57:01 Individuals Followed from Early Infection. Journal of Virology. 94. PMID 32350076 DOI: 10.1128/Jvi.02128-19  0.497
2020 Li Y, Altan E, Pilcher C, Hartogensis W, Hecht FM, Deng X, Delwart E. Semen virome of men with HIV on or off antiretroviral treatment. Aids (London, England). 34: 827-832. PMID 32271249 DOI: 10.1097/Qad.0000000000002497  0.574
2020 Webb K, Chitiyo V, Mahachi N, Mukungunugwa SH, Mushavi A, Zizhou S, Engelsmann B, Ferrand RA, Neuman M, Hartogensis W, Geng E. Improving Early Infant Diagnosis Observations: Estimates of timely HIV testing and mortality among HIV-exposed infants. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31913988 DOI: 10.1097/Qai.0000000000002263  0.427
2019 Anderson JL, Khoury G, Fromentin R, Solomon A, Chomont N, Sinclair E, Milush JM, Hartogensis W, Bacchetti P, Roche M, Tumpach C, Gartner M, Pitman MC, Epling CL, Hoh R, et al. Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. The Journal of Infectious Diseases. PMID 31796951 DOI: 10.1093/Infdis/Jiz509  0.571
2019 Lee E, von Stockenstrom S, Morcilla V, Odevall L, Hiener B, Shao W, Hartogensis W, Bacchetti P, Milush J, Liegler T, Sinclair E, Hatano H, Hoh R, Somsouk M, Hunt P, et al. The impact of antiretroviral therapy duration on the HIV-1 infection of T-cells within anatomic sites. Journal of Virology. PMID 31723024 DOI: 10.1128/Jvi.01270-19  0.564
2019 Christopoulos KA, Neilands TB, Hartogensis W, Geng EH, Sauceda J, Mugavero MJ, Crane HM, Fredericksen RJ, Moore RD, Mathews WC, Mayer KH, Chander G, Hurt CB, Johnson MO. Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care. Journal of Acquired Immune Deficiency Syndromes (1999). 82: 116-123. PMID 31513551 DOI: 10.1097/Qai.0000000000002117  0.528
2018 Clemenzi-Allen A, Hartogensis W, Cohen SE, Gandhi M, Geng E, Christopoulos K. Evaluating the Impact of Housing Status on Gonorrhea and Chlamydia Screening in an HIV Primary Care Setting. Sexually Transmitted Diseases. PMID 30383619 DOI: 10.1097/Olq.0000000000000939  0.433
2018 Namazi G, Fajnzylber JM, Aga E, Bosch R, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, et al. The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies. The Journal of Infectious Diseases. PMID 30085241 DOI: 10.1093/Infdis/Jiy479  0.49
2018 Chang CC, Naranbhai V, Stern J, Roche M, Dantanarayana A, Ke R, Tennakoon S, Solomon A, Hoh R, Hartogensis W, Hecht FM, Sikaris K, Price DJ, Elliott JH, Deeks SG, et al. Variation in cell associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator BMAL-1. Aids (London, England). PMID 30005017 DOI: 10.1097/Qad.0000000000001937  0.533
2017 Khoury G, Fromentin R, Solomon A, Hartogensis W, Killian M, Hoh R, Somsouk M, Hunt PW, Girling V, Sinclair E, Bacchetti P, Anderson JL, Hecht FM, Deeks SG, Cameron PU, et al. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy. The Journal of Infectious Diseases. 215: 911-919. PMID 28453847 DOI: 10.1093/Infdis/Jix039  0.495
2017 Rutishauser R, Hartogensis W, Deguit CD, Krone M, Hoh R, Hecht R, Pilcher CD, Bacchetti P, Deeks SG, Hunt PW, McCune JM. Early and Delayed Antiretroviral Therapy (ART) Result in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression. Aids Research and Human Retroviruses. PMID 28335609 DOI: 10.1089/Aid.2016.0324  0.464
2017 Bershetyn A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, Diero L, Bwana M, Braitstein P, Somi G, Kambugu A, Bukusi E, Hartogensis W, Glidden DV, Wools-Kaloustian K, Yiannoutsos C, Martin J, et al. The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28329184 DOI: 10.1093/Cid/Cix191  0.405
2017 Clemenzi-Allen AA, Hartogensis W, Geng E, Christopolous K. Housing Insecure HIV Patients Have Higher Positive Gonorrhea and Chlamydia Test Results but Lower Testing Rates in a Primary Care Setting Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1781  0.437
2017 Lee E, Stockenstrom Sv, Morcilla V, Shao W, Hartogensis W, Bacchetti P, Milush J, Hoh R, Somsouk M, Hunt PW, Fromentin R, Chomont N, Deeks SG, Hecht FrM, Palmer S. The impact of ART duration on the infection of T cells within anatomic sites Journal of Virus Eradication. 3: 9. DOI: 10.1016/S2055-6640(20)30530-6  0.301
2016 Christopoulos K, Hartogensis W, Glidden DV, Pilcher CD, Gandhi M, Geng EH. The lorenz curve: a novel method for understanding viral load distribution at the population level. Aids (London, England). PMID 27831945 DOI: 10.1097/Qad.0000000000001336  0.418
2016 Nititham J, Gupta R, Zeng X, Hartogensis W, Nixon DF, Deeks SG, Hecht FM, Liao W. Psoriasis risk SNPs and their association with HIV-1 control. Human Immunology. PMID 27810495 DOI: 10.1016/J.Humimm.2016.10.018  0.518
2016 Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a U.S. Public Health Setting. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27434707 DOI: 10.1097/Qai.0000000000001134  0.493
2016 Fromentin R, Bakeman W, Lawani MB, Khoury G, Hartogensis W, DaFonseca S, Killian M, Epling L, Hoh R, Sinclair E, Hecht FM, Bacchetti P, Deeks SG, Lewin SR, Sékaly RP, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. Plos Pathogens. 12: e1005761. PMID 27415008 DOI: 10.1371/Journal.Ppat.1005761  0.52
2015 Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, et al. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. The Lancet. Hiv. 2: e520-e529. PMID 26614966 DOI: 10.1016/S2352-3018(15)00226-X  0.56
2015 Christopoulos KA, Scheer S, Steward WT, Barnes R, Hartogensis W, Charlebois ED, Morin SF, Truong HM, Geng EH. Examining clinic-based and public health approaches to ascertainment of HIV care status. Journal of Acquired Immune Deficiency Syndromes (1999). 69: S56-62. PMID 25867779 DOI: 10.1097/Qai.0000000000000571  0.389
2015 Chang C, Cameron P, Elliott J, Perelson A, Roche M, Dantanarayana A, Solomon A, Naranbhai V, Tenakoon S, Hoh R, McMahon J, Sikaris K, Hartogensis W, Bacchetti P, Hecht F, et al. Time-associated changes in cell-associated HIV RNA in HIV-infected subjects on suppressive antiretroviral therapy - implications for clinical trials of cure interventions Journal of the International Aids Society. 18. DOI: 10.7448/Ias.18.5.20567  0.537
2014 Norström MM, Veras NM, Huang W, Proper MC, Cook J, Hartogensis W, Hecht FM, Karlsson AC, Karlsoon AC, Salemi M. Baseline CD4+ T cell counts correlates with HIV-1 synonymous rate in HLA-B*5701 subjects with different risk of disease progression. Plos Computational Biology. 10: e1003830. PMID 25187947 DOI: 10.1371/Journal.Pcbi.1003830  0.508
2013 Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. The Journal of Infectious Diseases. 208: 1202-11. PMID 23852127 DOI: 10.1093/Infdis/Jit311  0.552
2013 Vallabhaneni S, McConnell JJ, Loeb L, Hartogensis W, Hecht FM, Grant RM, Pilcher CD. Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men. Plos One. 8: e55397. PMID 23405145 DOI: 10.1371/Journal.Pone.0055397  0.426
2013 Perez CL, Milush JM, Buggert M, Eriksson EM, Larsen MV, Liegler T, Hartogensis W, Bacchetti P, Lund O, Hecht FM, Nixon DF, Karlsson AC. Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion. Aids Research and Human Retroviruses. 29: 602-12. PMID 23140171 DOI: 10.1089/Aid.2012.0171  0.55
2012 Norström MM, Buggert M, Tauriainen J, Hartogensis W, Prosperi MC, Wallet MA, Hecht FM, Salemi M, Karlsson AC. Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects. Journal of Virology. 86: 9802-16. PMID 22761389 DOI: 10.1128/Jvi.01165-12  0.517
2011 Facente SN, Pilcher CD, Hartogensis WE, Klausner JD, Philip SS, Louie B, Christopoulos KA, Dowling T, Colfax GN. Performance of risk-based criteria for targeting acute HIV screening in San Francisco. Plos One. 6: e21813. PMID 21755003 DOI: 10.1371/Journal.Pone.0021813  0.541
2011 Jain V, Sucupira MC, Bacchetti P, Hartogensis W, Diaz RS, Kallas EG, Janini LM, Liegler T, Pilcher CD, Grant RM, Cortes R, Deeks SG, Hecht FM. Differential persistence of transmitted HIV-1 drug resistance mutation classes. The Journal of Infectious Diseases. 203: 1174-81. PMID 21451005 DOI: 10.1093/Infdis/Jiq167  0.391
2011 Truong HM, Fritz K, McFarland W, Hartogensis W, Fiamma A, Coates TJ, Morin SF. Recent HIV type 1 infection among participants in a same-day mobile testing pilot study in Zimbabwe. Aids Research and Human Retroviruses. 27: 593-5. PMID 21087196 DOI: 10.1089/Aid.2010.0249  0.537
2010 Jain V, Liegler T, Vittinghoff E, Hartogensis W, Bacchetti P, Poole L, Loeb L, Pilcher CD, Grant RM, Deeks SG, Hecht FM. Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. Plos One. 5: e15510. PMID 21170322 DOI: 10.1371/Journal.Pone.0015510  0.537
2010 Hecht FM, Hartogensis W, Bragg L, Bacchetti P, Atchison R, Grant R, Barbour J, Deeks SG. HIV RNA level in early infection is predicted by viral load in the transmission source. Aids (London, England). 24: 941-5. PMID 20168202 DOI: 10.1097/Qad.0B013E328337B12E  0.522
2004 Louie LG, Hartogensis WE, Jackman RP, Schultz KA, Zijenah LS, Yiu CH, Nguyen VD, Sohsman MY, Katzenstein DK, Mason PR. Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation. The Journal of Infectious Diseases. 189: 1084-90. PMID 14999612 DOI: 10.1086/382030  0.487
2002 Zijenah LS, Hartogensis WE, Katzenstein DA, Tobaiwa O, Mutswangwa J, Mason PR, Louie LG. Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe. Human Immunology. 63: 1026-32. PMID 12392855 DOI: 10.1016/S0198-8859(02)00684-5  0.312
Show low-probability matches.